Strides Pharma, Inc.: Drug Recall

Recall #D-0293-2025 · 03/05/2025

Class II: Risk

Recall Details

Recall Number: D-0293-2025
Classification: Class II
Product Type: Drug
Recalling Firm: Strides Pharma, Inc.
Status: Ongoing
Date Initiated: 03/05/2025
Location: Chestnut Ridge, NY, United States
Voluntary/Mandated: Voluntary: Firm initiated
Product Quantity: 195,952 Cartons; 30 sachets/Carton.

Reason for Recall

Presence of foreign substance: Presence of Benzene.

Product Description

Testosterone Gel 1%, 2.5 grams, 30 Unit-dose packets in a carton, Rx only, Distributed by: Strides Pharma Inc., East Brunswick, NJ, NDC 64380-151-02

Distribution Pattern

Nationwide in the U.S

Other Recalls by Strides Pharma, Inc.

Class II: Risk 07/09/2025

Failed Dissolution Specifications.
Class II: Risk 03/05/2025

Presence of foreign substance: Presence of Benzene.
Class II: Risk 12/29/2023

Failed Dissolution Specifications
Class II: Risk 06/26/2023

Presence of Foreign Substance: Presence of a small piece of blue plastic embedded in the tablet.
Class II: Risk 07/19/2022

Presence of foreign tablet: 2.5 mg tablet in a 20 mg bottle of Prednisone Tablets

View all recalls by Strides Pharma, Inc. →

Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.